Slide 1 www.drsarma.in 1 Dr. R.V.S.N. Sarma., M.D., M.Sc., MANAGEMENT OF TYPE 2 DM A Rational Approach Slide 2 www.drsarma.in 2 Diabetes Mellitus 1.Type 2 DM (No more called…

Slide 1 Dr.Sarma@works A comprehensive review by Dr. R.V. S. N. Sarma, M.D., M.Sc., Metformin Revisited Slide 2 Dr.Sarma@works Diabetes Mellitus 1.Type 2 DM (NIDDM) 2.Not…

Microsoft PowerPoint - Grompe FAVideoAD 5-17-2011 KEN.ppt [Compatibility Mode]Markus Grompe, MDMarkus Grompe, MDp ,p , Oregon Health & Science UniversityOregon Health

jmg-0301_mg023525.pdfJ Med Genet 2003;40:1–10 Fanconi anaemia (FA) is an autosomal recessive disease characterised by congenital abnormalities, defective haemopoiesis,

UntitledFEATURE A Review of Fanconi Anemia for the Practicing Pediatrician Justin Triemstra, MD; An Pham, MD; Lindsay Rhodes, MS, CGC; Darrel J. Waggoner, MD; and Kenan Onel,

doi:10.1080Hwasun, Korea Abstract Fanconi anemia (FA) is an autosomal recessive chromosomal instability disorder, characterized by congenital anomalies, defective hematopoiesis

PII: S1097-2765(01)00172-1Molecular Cell, Vol. 7, 241–248, February, 2001, Copyright 2001 by Cell Press Positional Cloning of a Novel Fanconi Anemia Gene, FANCD2 a

Introduction Fanconi Anemia (FA) is a rare genetic disorder that is mainly inherited in an autosomal recessive pattern and is rarely X-linked. It was first described in 1927

Fanconi anemiaFanconi anemia Description Fanconi anemia is a condition that affects many parts of the body. People with this condition may have bone marrow failure, physical

HOYFanconi anemia: A model disease for studies on human genetics and advanced therapeutics Genome Instability and DNA Repair Group, Department of Genetics and Microbiology,